Delivery Order SPE2DB22D2211-SPE2DB23FPED0

Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $38
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $39,640 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by July 5, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands....
The Defense Logistics Agency awarded a $69,370 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by August 2, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands....
The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by August 1, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands....
The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. The firm fixed price order is for delivery of 4561327540 units of methotrexate, a chemotherapy drug, in 2mL vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on June 26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain...
The Defense Logistics Agency awarded a $69,370 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by July 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate will support the DLA's mission to provide...
The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for the supply of 1 gram/40 ml vials of methotrexate. The firm fixed price order is to provide 40 ml vials of the chemotherapy drug to locations in Conshohocken, Pennsylvania, with performance required from June 29-30, 2023. Amerisourcebergen will fulfill the order as the prime contractor, with the Defense Logistics Agency serving as the funding agency. The delivery order was issued against an...
The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injections. The firm fixed price order is for the delivery of 4562252108 units of methotrexate at 50 mg/2 ml per vial with a total of 2 ml per vial. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania between September 20-21, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other government...
The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by June 23, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate is consistent with the Defense Logistics Agency's...
The Defense Logistics Agency awarded a $97,070 delivery order to Amerisourcebergen Drug Corporation for the supply of 250 mg/10 ml vials of methotrexate. The firm fixed price order calls for the delivery of 10 ml vials of the chemotherapy drug to a facility in Conshohocken, Pennsylvania by July 17, 2023. Amerisourcebergen will perform as the prime contractor, supplying the Defense Logistics Agency with the requested pharmaceutical to support Department of Defense health programs. The order was...
The Defense Logistics Agency awarded a $69,370 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to support DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 17-18, 2023. No set aside designation or subcontractors were identified. This order was issued under DLA's pharmaceutical...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FPED0
    Delivery Order

The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate 50 mg/2 ml vials. The firm fixed price order is for 2 ml vials of the chemotherapy drug and will be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility. The prime contractor will deliver the products to the Defense Logistics Agency between September 14-15, 2023 to support the agency's medical supply needs. No major subcontractors or set aside designations were identified. This order is likely supporting the treatment of cancer or autoimmune conditions for military personnel and their families through the Defense Logistics Agency's medical supply chain management programs.

Generated 12/24/23, 3:30 AM